Publications for David Goldstein
Publications for David Goldstein
2016
O'Callaghan, C., Schofield, P., Butow, P., Nolte,
L., Price, M., Tsintziras, S., Sze, M., Thein, T.,
Yiu, D., Mireskandari, S., et al (2016). "I might
not have cancer if you didn't mention it": a
qualitative study on information needed by
culturally diverse cancer survivors. Supportive
Care in Cancer, 24(1), 409-418. <a
href="http://dx.doi.org/10.1007/s00520-015-281
1-9">[More Information]</a>
Beesley, V., Janda, M., Goldstein, D., Gooden,
H., Merrett, N., O'Connell, D., Rowlands, I.,
Wyld, D., Neale, R. (2016). A tsunami of unmet
needs: pancreatic and ampullary cancerpatients'
supportive care needs and use of community
andallied health services. Psycho-Oncology,
25(2), 150-157. <a
href="http://dx.doi.org/10.1002/pon.3887">[Mor
e Information]</a>
2015
Chandrasegaram, M., Goldstein, D., Simes, R.,
Gebski, V., Kench, J., Gill, A., Samra, J.,
Merrett, N., Richardson, A., Barbour, A. (2015).
Meta-analysis of radical resection rates and
margin assessment in pancreatic cancer. British
Journal of Surgery, 102(12), 1459-1472. <a
href="http://dx.doi.org/10.1002/bjs.9892">[More
Information]</a>
Sze, M., Butow, P., Bell, M., Vaccaro, L., Dong,
S., Eisenbruch, M., Jefford, M., Girgis, A., King,
M., McGrane, J., et al (2015). Migrant Health in
Cancer: Outcome Disparities and the
Determinant Role of Migrant-Specific Variables.
The Oncologist, 20, 523-531. <a
href="http://dx.doi.org/10.1634/theoncologist.20
14-0274">[More Information]</a>
Chan, D., Goldstein, D., Zalcberg, J. (2015).
Neuroendocrine tumours - Models for rare
tumour management. Cancer Forum, 39(1),
13-16.
2014
Burmeister, E., O'Connell, D., Beesley, V.,
Goldstein, D., Gooden, H., Janda, M., Jordan, S.,
Merrett, N., Payne, M., Wyld, D., et al (2015).
Describing Patterns of Care in Pancreatic
Cancer: A Population-Based Study. Pancreas,
44(8), 1259-1265. <a
href="http://dx.doi.org/10.1097/MPA.000000000
0000384">[More Information]</a>
McGrane, J., Butow, P., Sze, M., Eisenbruch,
M., Goldstein, D., King, M. (2014). Assessing
the invariance of a culturally competent
multi-lingual unmet needs survey for immigrant
and Australian-born cancer patients: a Rasch
analysis. Quality of Life Research, 23(10),
2819-2830. <a
href="http://dx.doi.org/10.1007/s11136-014-071
7-5">[More Information]</a>
Lee, C., Goldstein, D., Gibbs, E., Joensuu, H.,
Zalcberg, J., Verweij, J., Casali, P., Maki, R.,
Cioffi, A., Lord, S., et al (2015). Development
and validation of prognostic nomograms for
metastatic gastrointestinal stromal tumour treated
with imatinib. European Journal of Cancer,
51(7), 852-860. <a
href="http://dx.doi.org/10.1016/j.ejca.2015.02.01
5">[More Information]</a>
Bennett, B., Goldstein, D., Chen, M., Davenport,
T., Vollmer-Conna, U., Scott, E., Hickie, I.,
Lloyd, A. (2014). Characterization of Fatigue
States in Medicine and Psychiatry by Structured
Interview. Psychosomatic Medicine, 76(5),
379-388. <a
href="http://dx.doi.org/10.1097/PSY.000000000
0000061">[More Information]</a>
Davis, I., Long, A., Yip, S., Espinoza, D.,
Thompson, J., Kichenadasse, G., Harrision, M.,
Lowenthal, R., Pavlakis, N., Azad, A., Hudson,
A., Stockler, M., Martin, A., et al (2015).
EVERSUN: A phase 2 trial of alternating
sunitinib and everolimus as first line therapy for
advanced renal cell carcinoma. Annals of
Oncology, 26(6), 1118-1123. <a
href="http://dx.doi.org/10.1093/annonc/mdv078"
>[More Information]</a>
Pantaleo, M., Lolli, C., Nannini, M., Astolfi, A.,
Indio, V., Saponara, M., Urbini, M., La Rovere,
S., Gill, A., Goldstein, D., et al (2015). Good
survival outcome of metastatic SDH-deficient
gastrointestinal stromal tumors harboring SDHA
mutations. Genetics in Medicine, 17(5), 391-395.
<a
href="http://dx.doi.org/10.1038/gim.2014.115">[
More Information]</a>
Hillman, R., Garland, S., Gunathilake, M.,
Stevens, M., Kumaradevan, N., Lemech, C.,
Ward, R., Meagher, A., McHugh, L., Jin, F., et al
(2014). Human papillomavirus (HPV) genotypes
in an Australian sample of anal cancers.
International Journal of Cancer, 135(4),
996-1001. <a
href="http://dx.doi.org/10.1002/ijc.28730">[Mor
e Information]</a>
Goldstein, D., Bell, M., Butow, P., Sze, M.,
Vaccaro, L., Dong, S., Liauw, W., Hui, R.,
Tattersall, M., Ng, W., Vardy, J., King, M., et al
(2014). Immigrants' perceptions of the quality of
their cancer care: An Australian comparative
study, identifying potentially modifiable factors.
Annals of Oncology, 25(8), 1643-1649. <a
href="http://dx.doi.org/10.1093/annonc/mdu182"
>[More Information]</a>
2013
Publications for David Goldstein
Grimison, P., Phillips, F., Butow, P., White, K.,
Yip, D., Sardelic, F., Underhill, C., Tse, R.,
Simes, R., Turley, K., et al (2013). Are visiting
oncologists enough? A qualitative study of the
needs of Australian rural and regional cancer
patients, carers and health professionals.
Asia-Pacific Journal of Clinical Oncology, 9(3),
226-238. <a
href="http://dx.doi.org/10.1111/ajco.12014">[M
ore Information]</a>
Butow, P., Tattersall, M., Clayton, J., Goldstein,
D. (2013). Breaking Bad News and Truth
Disclosure in Australia. In Antonella Surbone,
Matjaz Zwitter, Mirjana Rajer, Richard Stiefel
(Eds.), New Challenges in Communication with
Cancer Patients, (pp. 377-387). New York:
Springer.
Park, S., Goldstein, D., Krishnan, A., Lin, C.,
Friedlander, M., Cassidy, J., Koltzenburg, M.,
Kiernan, M. (2013). Chemotherapy-induced
peripheral neurotoxicity: A critical analysis. CA:
A Cancer Journal for Clinicians, 63(6), 419-437.
<a
href="http://dx.doi.org/10.1002/caac.21204">[M
ore Information]</a>
Chou, A., Waddell, N., Cowley, M., Gill, A.,
Chang, D., Patch, A., Nones, K., Wu, J., Pinese,
M., Johns, A., Toon, C., et al (2013). Clinical
and molecular characterization of HER2
amplified-pancreatic cancer. Genome Medicine,
5(8), 1-11. <a
href="http://dx.doi.org/10.1186/gm482">[More
Information]</a>
Short (nee Rybovic), M., Goldstein, D., Halkett,
G., Reece, W., Borg, M., Zissiadis, Y.,
Kneebone, A., Spry, N. (2013). Impact of
Gemcitabine Chemotherapy and 3-Dimensional
Conformal Radiation Therapy/5-Fluorouracil on
Quality of Life of Patients Managed for
Pancreatic Cancer. International Journal of
Radiation: Oncology - Biology - Physics, 85(1),
157-162. <a
href="http://dx.doi.org/10.1016/j.ijrobp.2012.03.
003">[More Information]</a>
Butow, P., Aldridge, L., Bell, M., Sze, M.,
Eisenbruch, M., Jefford, M., Schofield, P.,
Girgis, A., King, M., Duggal, P., McGrane, J., et
al (2013). Inferior health-related quality of life
and psychological well-being in immigrant
cancer survivors: A population-based study.
European Journal of Cancer, 49(8), 1948-1956.
<a
href="http://dx.doi.org/10.1016/j.ejca.2013.01.01
1">[More Information]</a>
Bell, M., Butow, P., Goldstein, D. (2013).
Informatively missing quality of life and unmet
needs sex data for immigrant and
Anglo-Australian cancer patients and survivors.
Quality of Life Research, 22(10), 2757-2760. <a
href="http://dx.doi.org/10.1007/s11136-013-039
2-y">[More Information]</a>
Shaw, J., Butow, P., Sze, M., Young, J.,
Goldstein, D. (2013). Reducing disparity in
outcomes for immigrants with cancer: a
qualitative assessment of the feasibility and
acceptability of a culturally targeted
telephone-based supportive care intervention.
Supportive Care in Cancer, 21(8), 2297-2301. <a
href="http://dx.doi.org/10.1007/s00520-013-178
6-7">[More Information]</a>
Butow, P., Sze, M., Eisenbruch, M., Bell, M.,
Aldridge, L., Abdo, S., Mikhail (nee Tanious),
M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al
(2013). Should culture affect practice? A
comparison of prognostic discussions in
consultations with immigrant versus native-born
cancer patients. Patient Education and
Counseling, 92(2), 246-252. <a
href="http://dx.doi.org/10.1016/j.pec.2013.03.00
6">[More Information]</a>
Kiely, B., Martin, A., Tattersall, M., Nowak, A.,
Goldstein, D., Wilcken, N., Wyld, D., Abdi, E.,
Glasgow, A., Beale, P., Stockler, M., et al
(2013). The Median Informs the Message:
Accuracy of Individualized Scenarios for
Survival Time Based on Oncologists' Estimates.
Journal of Clinical Oncology, 31(28),
3565-3571. <a
href="http://dx.doi.org/10.1200/JCO.2012.44.78
21">[More Information]</a>
Butow, P., Bell, M., Aldridge, L., Sze, M.,
Eisenbruch, M., Jefford, M., Schofield, P.,
Girgis, A., King, M., Duggal, P., et al (2013).
Unmet needs in immigrant cancer survivors: a
cross-sectional population-based study.
Supportive Care in Cancer, 21(9), 2509-2520. <a
href="http://dx.doi.org/10.1007/s00520-013-181
9-2">[More Information]</a>
2012
Butow, P., Lobb, E., Jefford, M., Goldstein, D.,
Eisenbruch, M., Girgis, A., King, M., Sze, M.,
Aldridge, L., Schofield, P. (2012). A bridge
between cultures: interpreters' perspectives of
consultations with migrant oncology patients.
Supportive Care in Cancer, 20(2), 235-244. <a
href="http://dx.doi.org/10.1007/s00520-010-104
6-z">[More Information]</a>
Goldstein, D., Bennett, B., Webber, K., Boyle,
F., De Souza, P., Wilcken, N., Scott, E., Toppler,
R., Murie, P., O'Malley, L., Hickie, I., et al
(2012). Cancer-Related Fatigue in Women With
Breast Cancer: Outcomes of a 5-Year
Prospective Cohort Study. Journal of Clinical
Oncology, 30(15), 1805-1812. <a
href="http://dx.doi.org/10.1200/JCO.2011.34.61
48">[More Information]</a>
Publications for David Goldstein
Bennett, B., Park, S., Lin, C., Friedlander, M.,
Kiernan, M., Goldstein, D. (2012). Impact of
oxaliplatin-induced neuropathy: a patient
perspective. Supportive Care in Cancer, 20(11),
2959-2967. <a
href="http://dx.doi.org/10.1007/s00520-012-142
8-5">[More Information]</a>
Cameron, B., Bennett, B., Li, H., Boyle, F.,
deSouza, P., Wilcken, N., Friedlander, M.,
Goldstein, D., Lloyd, A. (2012). Post-cancer
fatigue is not associated with immune activation
or altered cytokine production. Annals of
Oncology, 23(11), 2890-2895. <a
href="http://dx.doi.org/10.1093/annonc/mds108"
>[More Information]</a>
Mitchison, D., Butow, P., Sze, M., Aldridge, L.,
Hui, R., Vardy, J., Eisenbruch, M., Iedema, R.,
Goldstein, D. (2012). Prognostic communication
preferences of migrant patients and their
relatives. Psycho-Oncology, 21(5), 496-504. <a
href="http://dx.doi.org/10.1002/pon.1923">[Mor
e Information]</a>
Butow, P., Phillips, F., Schweder, J., White, K.,
Underhill, C., Goldstein, D. (2012). Psychosocial
well-being and supportive care needs of cancer
patients living in urban and rural/regional areas:
a systematic review. Supportive Care in Cancer,
20(1), 1-22. <a
href="http://dx.doi.org/10.1007/s00520-011-127
0-1">[More Information]</a>
Ngan, S., Burmeister, B., Fisher, R., Solomon,
M., Goldstein, D., Joseph, D., Ackland, S.,
Schache, D., McClure, B., McLachlan, S., et al
(2012). Randomized Trial of Short-Course
Radiotherapy Versus Long-Course
Chemoradiation Comparing Rates of Local
Recurrence in Patients With T3 Rectal Cancer:
Trans-Tasman Radiation Oncology Group Trial
01.04. Journal of Clinical Oncology, 30(31),
3827-3833. <a
href="http://dx.doi.org/10.1200/JCO.2012.42.95
97">[More Information]</a>
Goldstein, D., Spry, N., Cummins, M., Brown,
C., van Hazel, G., Carroll, S., Selva-Nayagam,
S., Borg, M., Ackland, S., Wratten, C., Hruby,
G., Horvath, L., Gebski, V., et al (2012). The
GOFURTGO Study: AGITG Phase II Study of
fixed dose rate gemcitabine-oxaliplatin
integrated with concomitant 5FU and 3-D
conformal radiotherapy for the treatment of
localised pancreatic cancer. British Journal of
Cancer, 106(1), 61-69. <a
href="http://dx.doi.org/10.1038/bjc.2011.526">[
More Information]</a>
2011
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Dose
effects of oxaliplatin on persistent and transient
na conductances and the development of
neurotoxicity. PloS One, 6(4), e18469-e18469.
<a
href="http://dx.doi.org/10.1371/journal.pone.001
8469">[More Information]</a>
Butow, P., Sze, M., Duggal-Beri, P., Mikhail
(nee Tanious), M., Eisenbruch, M., Jefford, M.,
Schofield, P., Girgis, A., King, M., Goldstein, D.
(2011). From inside the bubble: migrants'
perceptions of communication with the cancer
Team. Supportive Care in Cancer, 19(2),
281-290. <a
href="http://dx.doi.org/10.1007/s00520-010-081
7-x">[More Information]</a>
Butow, P., Bell, M., Goldstein, D., Sze, M.,
Aldridge, L., Abdo, S., Mikhail (nee Tanious),
M., Dong, S., Iedema, R., Ashgari, R., Hui, R., et
al (2011). Grappling with cultural differences;
Communication between oncologists and
immigrant cancer patients with and without
interpreters. Patient Education and Counseling,
84, 398-405. <a
href="http://dx.doi.org/10.1016/j.pec.2011.01.03
5">[More Information]</a>
Webber, K., Mok, K., Bennett, B., Lloyd, A.,
Friedlander, M., Juraskova, I., Goldstein, D.
(2011). If I Am in the Mood, I Enjoy It: An
Exploration of Cancer-Related Fatigue and
Sexual Functioning in Women with Breast
Cancer. The Oncologist, 16, 1333-1344. <a
href="http://dx.doi.org/10.1634/theoncologist.20
11-0100">[More Information]</a>
Butow, P., Goldstein, D., Bell, M., Sze, M.,
Aldridge, L., Abdo, S., Mikhail (nee Tanious),
M., Dong, S., Iedema, R., Vardy, J., et al (2011).
Interpretation in Consultations With Immigrant
Patients With Cancer: How Accurate Is It?
Journal of Clinical Oncology, 29(20),
2801-2807. <a
href="http://dx.doi.org/10.1200/JCO.2010.34.33
35">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Long-Term
Neuropathy After Oxaliplatin Treatment:
Challenging the Dictum of Reversibility. The
Oncologist, 16(5), 708-716. <a
href="http://dx.doi.org/10.1634/theoncologist.20
10-0248">[More Information]</a>
Park, S., Goldstein, D., Lin, C., Krishnan, A.,
Friedlander, M., Kiernan, M. (2011).
Neuroprotection for Oxaliplatin-Induced
Neurotoxicity: What Happened to Objective
Assessment? Journal of Clinical Oncology,
29(18), e553-e554. <a
href="http://dx.doi.org/10.1200/JCO.2011.34.82
27">[More Information]</a>
Luckett, T., Goldstein, D., Butow, P., Gebski, V.,
Aldridge, L., McGrane, J., Ng, W., King, M.
Publications for David Goldstein
(2011). Psychological morbidity and quality of
life of ethnic minority patients with cancer: a
systematic review and meta-analysis. The Lancet
Oncology, 12(13), 1240-1248. <a
href="http://dx.doi.org/10.1016/S1470-2045(11)
70212-1">[More Information]</a>
Tebbutt, N., Murphy, F., Zannino, D., Wilson,
C., Cummins, M., Abdi, E., Strickland, A.,
Lowenthal, R., Marx, G., Karapetis, C., Shannon,
J., Simes, R., et al (2011). Risk of arterial
thromboembolic events in patients with
advanced colorectal cancer receiving
bevacizumab. Annals of Oncology, 22(8),
1834-1838. <a
href="http://dx.doi.org/10.1093/annonc/mdq702"
>[More Information]</a>
Sze, M., Butow, P., Goldstein, D., Jefford, M.,
Girgis, A., Eisenbruch, M., Bell, M., Vaccaro,
L., Dong, S., Liauw, W., et al (2011). Shared
Decision Making in Immigrants With
Cancer. Psycho-Oncology, 20(Suppl 2), 12-13.
Clarke, S., Yip, S., Brown, C., van Hazel, G.,
Ransom, D., Goldstein, D., Jeffrey, G., Tebbutt,
N., Buck, M., Lowenthal, R., Boland, A.,
Gebski, V., Simes, R., et al (2011). Single-agent
irinotecan or 5-fluorouracil and leucovorin
(FOLFIRI) as second-line chemotherapy for
advanced colorectal cancer; results of a
randomised phase II study (DaVINCI) and
meta-analysis. European Journal of Cancer,
47(12), 1826-1836. <a
href="http://dx.doi.org/10.1016/j.ejca.2011.04.02
4">[More Information]</a>
Leighl, N., Shepherd, H., Butow, P., Clarke, S.,
McJannett, M., Beale, P., Wilcken, N., Moore,
M., Chen, E., Goldstein, D., Horvath, L.,
Tattersall, M., et al (2011). Supporting Treatment
Decision Making in Advanced Cancer: A
Randomized Trial of a Decision Aid for Patients
With Advanced Colorectal Cancer Considering
Chemotherapy. Journal of Clinical Oncology,
29(15), 2077-2084. <a
href="http://dx.doi.org/10.1200/JCO.2010.32.07
54">[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2011). Utilising
natural activity to dissect the Pathophysiology of
acute oxaliplatin-induced neuropathy.
Experimental Neurology, 227(1), 120-127. <a
href="http://dx.doi.org/10.1016/j.expneurol.2010
.10.002">[More Information]</a>
2010
Butow, P., Lobb, E., Jefford, M., Goldstein, D.,
Eisenbruch, M., Girgis, A., King, M., Sze, M.,
Aldridge, L., Schofield, P. (2010). A bridge
between cultures: interpreters' perspectives of
consultations with migrant oncology patients.
Supportive Care in Cancer, , 1-10. <a
href="http://dx.doi.org/10.1007/s00520-010-104
6-z">[More Information]</a>
Lovell, M., Forder, P., Stockler, M., Butow, P.,
Briganti, E., Chye, R., Goldstein, D., Boyle, F.
(2010). A Randomized Controlled Trial of a
Standardized Educational Intervention for
Patients with Cancer Pain. Journal of Pain and
Symptom Management, 40(1), 49-59. <a
href="http://dx.doi.org/10.1016/j.jpainsymman.2
009.12.013">[More Information]</a>
Sjoquist, K., Goldstein, D., Bester, L. (2010). A
serious complication of selected internal
radiation therapy: case report and literature
review. The Oncologist, 15(8), 830-835. <a
href="http://dx.doi.org/10.1634/theoncologist.20
10-0074">[More Information]</a>
Blinman, P., Duric, V., Nowak, A., Beale, P.,
Clarke, S., Briscoe, K., Boyce, A., Goldstein, D.,
Hudson, M., Stockler, M. (2010). Adjuvant
chemotherapy for early colon cancer: What
survival benefits make it worthwhile? European
Journal of Cancer, 46(10), 1800-1807. <a
href="http://dx.doi.org/10.1016/j.ejca.2009.12.03
2">[More Information]</a>
Neoptolemos, J., Stocken, D., Bassi, C., Ghaneh,
P., Cunningham, D., Goldstein, D., Padbury, R.,
Moore, M., Gallinger, S., Mariette, C., et al
(2010). Adjuvant Chemotherapy With
Fluorouracil Plus Folinic Acid vs Gemcitabine
Following Pancreatic Cancer Resection: A
Randomized Controlled Trial. JAMA: The
Journal of the American Medical Association,
304(10), 1073-1081. <a
href="http://dx.doi.org/10.1001/jama.2010.1275"
>[More Information]</a>
Goldstein, D., Gainford, M., Brown, C., Tebbutt,
N., Ackland, S., van Hazel, G., Jefford, M.,
Abdi, E., Selva-Nayagam, S., Gebski, V., Miller,
D., et al (2010). Fixed-dose-rate gemcitabine
combined with cisplatin in patients with
inoperable biliary tract carcinomas. Cancer
Chemotherapy and Pharmacology, , 1-7. <a
href="http://dx.doi.org/10.1007/s00280-010-135
1-8">[More Information]</a>
Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui,
M., Jin, R., Tobias, V., Samra, J., Goldstein, D.,
Smith, C., Smith, R., Sywak, M., Sidhu, S.,
Robinson, B., Eckstein, R., Benn, D.,
Clifton-Bligh, R., et al (2010).
Immunohistochemistry for SDHB Divides
Gastrointestinal Stromal Tumors (GISTs) into 2
Distinct Types. American Journal of Surgical
Pathology, 34(5), 636-644. <a
href="http://dx.doi.org/10.1097/PAS.0b013e318
1d6150d">[More Information]</a>
Wu, M., Goldstein, D., Alidge, L., McGrane, J.,
Girgis, A., Eisenbruch, M., King, M., Jefford,
Publications for David Goldstein
M., Schofield, P., Sze, M. (2010). Morbidity,
Unmet needs, quality of life and patterns of care
in CALD cancer patients in Prince of Wales
Hospital. Sydney Cancer Conference 2010,
Sydney, Australia: University of Sydney.
Koczwara, B., Francis, K., Marine, F., Goldstein,
D., Underhill, C., Olver, I. (2010). Reaching
further with online education? The development
of an effective online program in palliative
oncology. Journal of Cancer Education, 25(3),
317-323. <a
href="http://dx.doi.org/10.1007/s13187-009-003
7-6">[More Information]</a>
2009
Park, S., Goldstein, D., Lin, C., Krishnan, A.,
Friedlander, M., Kiernan, M. (2009). Acute
abnormalities of sensory nerve function
associated with oxaliplatin-induced
neurotoxicity. Journal of Clinical Oncology,
27(8), 1243-1249. <a
href="http://dx.doi.org/10.1200/JCO.2008.19.34
25">[More Information]</a>
Girgis, A., Hansen, V., Goldstein, D. (2009). Are
Australian oncology health professionals burning
out? A view from the trenchs. European Journal
of Cancer, 45, 393-399. <a
href="http://dx.doi.org/10.1016/j.ejca.2008.09.02
9">[More Information]</a>
Underhill, C., Bartel, R., Goldstein, D.,
Snodgrass, H., Begbie, S., Yates, P., White, K.,
Jong, K., Grogan, P. (2009). Mapping oncology
services in regional and rural Australia.
Australian Journal of Rural Health, 17, 321-329.
<a
href="http://dx.doi.org/10.1111/j.1440-1584.200
9.01106.x">[More Information]</a>
Chua, W., Goldstein, D., Lee, C., Dhillon, H.,
Michael, M., Mitchell, P., Clark, S., Iacopetta, B.
(2009). Molecular markers of response and
toxicity to FOLFOX chemotherapy in metastatic
colorectal cancer. British Journal of Cancer,
101(6), 998-1004. <a
href="http://dx.doi.org/10.1038/sj.bjc.6605239">
[More Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2009).
Oxaliplatin-Induced Lhermitte's Phenomenon as
a Manifestation of Severe Generalized
Neurotoxicity. Neuro-Oncology, 77(6), 342-348.
<a
href="http://dx.doi.org/10.1159/000265940">[M
ore Information]</a>
Park, S., Lin, C., Krishnan, A., Goldstein, D.,
Friedlander, M., Kiernan, M. (2009).
Oxaliplatin-induced neurotoxicity: changes in
axonal excitability precede development of
neuropathy. Brain, 132(10), 2712-2723. <a
href="http://dx.doi.org/10.1093/brain/awp219">[
More Information]</a>
Van Hazel, G., Pavlakis, N., Goldstein, D.,
Olver, I., Tapner, M., Price, D., Bower, G.,
Briggs, G., Rossleigh, M., Taylor, D., George, J.
(2009). Treatment of Fluorouracil-Refractory
Patients With Liver Metastases From Colorectal
Cancer by Using Yttrium-90 Resin Microspheres
Plus Concomitant Systemic Irinotecan
Chemotherapy. Journal of Clinical Oncology,
27(25), 4089-4095. <a
href="http://dx.doi.org/10.1200/JCO.2008.20.81
16">[More Information]</a>
Lee, C., Hadley, A., DeSilva, K., Smith, G.,
Goldstein, D. (2009). When is a GIST not a
GIST? A case report of synchronous metastatic
gastrointestinal stromal tumor and fibromatosis.
World Journal of Surgical Oncology, 7(8), 1-4.
<a
href="http://dx.doi.org/10.1186/1477-7819-7-8"
>[More Information]</a>
2008
Butow, P., Girgis, A., Goldstein, D., Eisenbruch,
M., Schofield, P., King, M., Jefford, M.,
Duggal-Beri, P., Sze, M., Mikhail (nee Tanious),
M., et al (2008). Barriers to research with cancer
patients from culturally and linguistically diverse
(CALD) communities in Australia.
Psycho-Oncology, 17, S280-S280.
Shepherd, L., Goldstein, D., Olver, I., Parle, M.
(2008). Enhancing psychosocial care for people
with cancer in rural communities: what can
remote counselling offer? Australian Health
Review, 32(3), 423-438. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18666870">[More Information]</a>
Park, S., Krishnan, A., Lin, C., Goldstein, D.,
Friedlander, M., Kiernan, M. (2008).
Mechanisms underlying chemotherapy-induced
neurotoxicity and the potential for
neuroprotective strategies. Current Medicinal
Chemistry, 15(29), 3081-3094. <a
href="http://dx.doi.org/10.2174/0929867087868
48569">[More Information]</a>
Vonlaufen, A., Joshi, S., Qu, C., Phillips, P., Xu,
Z., Parker, N., Toi, C., Pirola, R., Wilson, J.,
Goldstein, D., et al (2008). Pancreatic stellate
cells: partners in crime with pancreatic cancer
cells. Cancer Research, 68(7), 2085-2093. <a
href="http://dx.doi.org/10.1158/0008-5472.CAN
-07-2477">[More Information]</a>
2007
Xavier, K., Shepherd, L., Goldstein, D. (2007).
Clinical supervision and education via
videoconference: a feasibility project. Journal of
Telemedicine and Telecare, 13(4), 206-209. <a
Publications for David Goldstein
href="http://dx.doi.org/10.1258/1357633077809
07996">[More Information]</a>
Stockler, M., O'Connell, R., Nowak, A.,
Goldstein, D., Turner, J., Wilcken, N., Wyld, D.,
Abdi, E., Glasgow, A., Beale, P., Dhillon, H.,
Heritier, S., Carter, C., Hickie, I., Simes, R., et al
(2007). Effect of sertraline on symptoms and
survival in patients with advanced cancer, but
without major depression: a placebo-controlled
double-blind randomised trial. Lancet Oncology,
8(7), 603-612. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17548243">[More Information]</a>
Moore, M., Goldstein, D., Hamm, J., Figer, A.,
Hecht, J., Gallinger, S., Au, H., Murawa, P.,
Walde, D., Wolff, R., et al (2007). Erlotinib Plus
Gemcitabine Compared With Gemcitabine Alone
in Patients With Advanced Pancreatic Cancer: A
Phase III Trial of the National Cancer Institute of
Canada Clinical Trials Group. Journal of
Clinical Oncology, 25(15), 1960-1966. <a
href="http://dx.doi.org/10.1200/JCO.2006.07.95
25">[More Information]</a>
Clarke, S., Goldstein, D., Mitchell, P., Michael,
M., Beale, P., Friedlander, M., Zalcberg, J.,
White, S. (2007). Modification of Leucovorin
Dose Within a Simplified FOLFOX Regimen
Improves Tolerability Without Compromising
Efficacy. Clinical Colorectal Cancer, 6(8),
578-582. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17681104">[More Information]</a>
Bennett, B., Goldstein, D., Friedlander, M.,
Hickie, I., Lloyd, A. (2007). The experience of
cancer related fatigue and chronic fatigue
syndrome: A qualitative and comparative study.
Journal of Pain and Symptom Management,
34(2), 126-135. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17544246">[More Information]</a>
Bennett, B., Goldstein, D., Friedlander, M.,
Hickie, I., Lloyd, A. (2007). The Experience of
Cancer-Related Fatigue and Chronic Fatigue
Syndrome: A Qualitative and Comparative
Study. Journal of Pain and Symptom
Management, 34(2), 126-135. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17544246">[More Information]</a>
Butow, P., Eisenbruch, M., Goldstein, D.,
Duggal-Beri, P., Jefford, M., Schofield, P.,
Girgis, A., King, M. (2007). Unmet needs in
Chinese, Greek and Arabic speaking cancer
patients in Australia. Psycho-Oncology, 16(9),
S77-S78.
Leighl, N., Shepherd, H., Butow, P., Clarke, S.,
McJannett, M., Beale, P., Wilcken, N., Moore,
M., Chen, E., Tattersall, M., Goldstein, D.
(2007). When the goal is not cure: A randomized
trial of a patient decision aid in advanced
colorectal cancer. Journal of Clinical Oncology,
25(18S), 6509.
2006
Mitchell, P., Goldstein, D., Michael, M., Beale,
P., Friedlander, M., Zalcberg, J., White, S.,
Thomson, J., Clarke, S. (2006). Addition of
gabapentin to a modified FOLFOX regimen does
not reduce oxaliplatin-induced neurotoxicity.
Clinical Colorectal Cancer, 6(2), 146-151. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16945171">[More Information]</a>
Dalton, L., Luxford, K., Boyle, F., Goldstein, D.,
Underhill, C., Yates, P. (2006). An educational
workshop program for rural practitioners to
encourage best practice for delivery of systemic
adjuvant therapy. Journal of Cancer Education,
21(1), 35-39. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16918288">[More Information]</a>
Yip, D., Karapetis, C., Strickland, A., Steer, C.,
Goldstein, D. (2006). Chemotherapy and
radiotherapy for inoperable advanced pancreatic
cancer. Cochrane Database of Systematic
Reviews, 3, CD002093-CD002093. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16855985">[More Information]</a>
Goldstein, D., Bennett, B., Friedlander, M.,
Davenport, T., Hickie, I., Lloyd, A. (2006).
Fatigue states after cancer treatment occur both
in association with, and independent of, mood
disorder: a longitudinal study. BMC Cancer, 6,
1-8. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17026776">[More Information]</a>
Harrison, M., Goldstein, D. (2006). Management
of metastatic gastrointestinal stromal tumour in
the Glivec era: a practical case-based approach.
Internal Medicine Journal, 36(6), 367-377. <a
href="http://dx.doi.org/10.1111/j.1445-5994.200
6.01077.x">[More Information]</a>
Goldstein, D., Ackland, S., Bell, D., Olver, I.,
Davis, I., Rosenthal, M., Toner, G., Pinel, M.,
Byrne, M. (2006). Phase II study of vinflunine in
patients with metastatic renal cell carcinoma.
Investigational New Drugs, 24(5), 429-434. <a
href="http://dx.doi.org/10.1007/s10637-006-643
7-0">[More Information]</a>
Grimison, P., Chin, M., Harrison, M., Goldstein,
Publications for David Goldstein
D. (2006). Primary pancreatic
lymphoma--pancreatic tumours that are
potentially curable without resection, a
retrospective review of four cases. BMC Cancer,
4(6), 117. <a
href="http://dx.doi.org/10.1186/1471-2407-6-11
7">[More Information]</a>
Michael, M., Goldstein, D., Clarke, S., Milner,
A., Beale, P., Friedlander, M., Mitchell, P.
(2006). Prognostic Factors Predictive of
Response and Survival to a Modified FOLFOX
Regimen: Importance of an Increased Neutrophil
Count. Clinical Colorectal Cancer, 6(4),
297-304.
Stockler, M., Heritier, S., Nowak, A., Goldstein,
D., Turner, J., Jefford, M., Glasgow, A., Abdi,
E., Beale, P., Carter, C. (2006). The time taken to
complete quality of life questionnaires in an
advanced cancer trial. Journal of Clinical
Oncology, 24(18S), 491s-491s.
Shepherd, L., Goldstein, D., Whitford, H.,
Thewes, B., Brummell, V., Hicks, M. (2006).
The Utility of Videoconferencing to Provide
Innovative Delivery of Psychological Treatment
for Rural Cancer Patients: Results of a Pilot
Study. Journal of Pain and Symptom
Management, 32(5), 453-461. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17085271">[More Information]</a>
Barlow-Stewart, K., Yeo, S., Meiser, B.,
Goldstein, D., Tucker, K., Eisenbruch, M.
(2006). Toward cultural competence in cancer
genetic counseling and genetics education:
lessons learned from Chinese-Australians.
Genetics in Medicine, 8(1), 24-32. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16418596">[More Information]</a>
2005
Mitchell, P., Goldstein, D., Michael, M., Beale,
P., Friedlander, M., Zalcberg, J., White, S.,
Clarke, S. (2005). Addition of gabapentin (G) to
a modified FOLFOX regimen does not reduce
neurotoxicity in patients (pts) with advanced
colorectal cancer (CRC). Journal of Clinical
Oncology, 23(No 16S (June 1 Supplement)),
3581-3581.
Grimison, P., Goldstein, D., Yu, L. (2005). An
unusual abdominal mass. Gut (English Edition):
an international journal of gastroenterology and
hepatology, 54(4), 478. <a
href="http://dx.doi.org/10.1136/gut.2004.051342
">[More Information]</a>
Goldstein, D., Mitchell, P., Michael, M., Beale,
P., Friedlander, M., Zalcberg, J., White, S.,
Clarke, S. (2005). Australian experience of a
modified schedule of FOLFOX with high
activity and tolerability and improved
convenience in untreated metastatic colorectal
cancer patients. British Journal of Cancer, 92(5),
832-837. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15756253">[More Information]</a>
Thewes, B., Meiser, B., Taylor, A., Phillips, K.,
Pendlebury, S., Capp, A., Dalley, D., Goldstein,
D., Baber, R., Friedlander, M. (2005). Fertilityand menopause-related information needs of
younger women with a diagnosis of early breast
cancer. Journal of Clinical Oncology, 23(22),
5155-5165. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16051957">[More Information]</a>
Sunghan, K., Goldstein, D., Hasher, L., Zacks, R.
(2005). Framing effects in younger and older
adults. Journal of Gerontology Series B:
Psychological Sciences and Social Sciences,
60(4), P215-8. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15980289">[More Information]</a>
Goldstein, D., Tan, B., Rossleigh, M., Haindl,
W., Walker, B., Dixon, J. (2005).
Gastrointestinal Stromal Tumours: Correlation of
18F-FDG Gamma Camera-Based Coincidence
Positron Emission Tomography with CT for the
Assessment of Treatment Response – An AGITG
Study. Oncology, 69(4), 326-332. <a
href="http://dx.doi.org/10.1159/000089765">[M
ore Information]</a>
Marx, G., Taylor, J., Goldstein, D. (2005).
Outpatient treatment with subcutaneous
interleukin-2, interferon alpha and fluorouracil in
patients with metastatic renal cancer: an
Australian experience. Internal Medicine
Journal, 35(1), 34-38. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15667466">[More Information]</a>
Yeo, S., Meiser, B., Barlow-Stewart, K.,
Goldstein, D., Tucker, K., Eisenbruch, M.
(2005). Understanding community beliefs of
Chinese-Australians about cancer: initial insights
using an ethnographic approach.
Psycho-Oncology, 14(3), 174-186. <a
href="http://dx.doi.org/10.1002/pon.831">[More
Information]</a>
2004
Hughes, B., Yip, D., Chao, M., Gibbs, P.,
Carroll, S., Goldstein, D., Burmeister, B.,
Karapetis, C. (2004). Audit Of Postoperative
Chemoradiotherapy As Adjuvant Therapy For
Resected Gastroesophageal Adenocarcinoma: An
Publications for David Goldstein
Australian Multicentre Experience. ANZ Journal
of Surgery, 74(11), 951-956.
Hagerty, R., Butow, P., Ellis, P., Lobb, E.,
Pendlebury, S., Tattersall, M., Leighl, N.,
Goldstein, D., Kai Lo, S. (2004). Cancer Patient
Preferences For Communication Of Prognosis In
The Metastatic Setting. Journal of Clinical
Oncology, 22(9), 1721-1730.
Hughes, B., Yip, D., Goldstein, D., Waring, P.,
Beshay, V., Chong, G. (2004). Cerebral Relapse
Of Metastatic Gastrointestinal Stromal Tumor
During Treatment With Imatinib Mesylate: Case
Report. BMC Cancer, 4(1), 74-80.
Robotin, M., Law, M., Milliken, S., Goldstein,
D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A.
(2004). Clinical characteristics and determinants
of survival following AIDS- related
non-Hodgkin’s lymphoma in a population-based
case series in Sydney, Australia. HIV Medicine,
5, 377-384.
Robotin, M., Law, M., Milliken, S., Goldstein,
D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A.
(2004). Clinical Features And Predictors Of
Survival Of AIDS-Related Non-Hodgkin'S
Lymphoma In A Population-Based Case Series
In Sydney, Australia. HIV Medicine, 5(5),
377-384.
Apte, M., Park, S., Phillips, P., Santucci, N.,
Goldstein, D., Kumar, R., Ramm, G., Buchler,
M., Friess, H., McCarroll, J., et al (2004).
Desmoplastic reaction in pancreatic cancer: role
of pancreatic stellate cells. Pancreas, 29(3),
179-187.
Brown, R., Butow, P., Sharrock, M., Henman,
M., Boyle, F., Goldstein, D., Tattersall, M.
(2004). Education And Role Modelling For
Clinical Decisions With Female Cancer Patients.
Health Expectations, 7(4), 303-316.
Bennett, B., Goldstein, D., Lloyd, A., Davenport,
T., Hickie, I. (2004). Fatigue and psychological
distress - exploring the relationship in women
treated for breast cancer. European Journal of
Cancer, 40(11), 1689-1695. <a
href="http://dx.doi.org/10.1016/j.ejca.2004.03.02
1">[More Information]</a>
Eisenbruch, M., Yeo, S., Meiser, B., Goldstein,
D., Tucker, K., Barlow-Stewart, K. (2004).
Optimising clinical practice in cancer genetics
with cultural competence: lessons to be learned
from ethnographic research with
Chinese-Australians. Social Science and
Medicine, 59(2), 235-248. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15110416">[More Information]</a>
Heathcote (nee Jong), K., Heathcote (nee Jong),
K., Smith, D., Smith, D., Yu, X., Yu, X.,
O'Connell, D., O'Connell, D., Goldstein, D.,
Goldstein, D., Armstrong, B., Armstrong, B.
(2004). Remoteness Of Residence And Survival
From Cancer In New South Wales. Medical
Journal of Australia, 180(12), 618-622. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15200358">[More Information]</a>
2002
Goldstein, D., Thewes, B., Butow, P. (2002).
Communicating in a multicultural society II:
Greek community attitudes towards cancer in
Australia. Internal Medicine Journal, 32(7),
289-296.
2001
Meiser, B., Eisenbruch, M., Barlow, R.,
Goldstein, D., Steel, Z., Tucker, K. (2001).
Cultural aspects of cancer genetics: setting a
research agenda. Journal of Medical Genetics,
38, 425-429.